ERBB2 and neoplasm: Breast carcinoma is a complex disease, and its molecular diagnosis and therapeutic indication are based on histopathological findings from tissue biopsy samples in which the presence and expression levels of estrogen and progesterone hormone receptors (ER and PR) and growth receptors (HER2) in the membrane of the tumor cells are investigated [3].